12,012 Residents Of Mukomuko Regency Have Completed Dose Of Vaccination

BENGKULU - The Mukomuko Regency COVID-19 Handling Task Force, Bengkulu Province stated, 12,012 people out of 164,208 targeted residents had received injections of COVID-19 vaccine doses III or complementary. as many as 12,012 people who have received the third dose of COVID-19 vaccine spread across a number of areas. Of the 12,012 people who have received this complementary vaccine, there are 882 health workers, 6,684 public service officers, and 4,446 residents who received the mutual cooperation vaccine. Bustam said , 6,684 public service officers who have undergone booster vaccinations consist of personnel from the Kodim, Polres, Brimob, District Attorney, District Court, KPPN, Religious Courts, journalists, BPJS, government employees, BRI, and state civil servants (ASN) in the local district government. and the general public. Furthermore, said Bustam, his party will continue to provide dose III vaccine to residents who have been vaccinated ksin dose II. He stated that although the local government gave vaccine dose III to local residents, the administration of vaccine doses I to II to local residents was still ongoing. The targeted residents have received the first and second doses of the COVID-19 vaccine.

A total of 90,540 people who have received the complete vaccine consist of 1,238 health workers, 55,513 public service workers, 4,253 elderly people (elderly), 11,288 adolescents aged 12-17 years, 12,953 children aged 6-11 years, and 5,295 recipients. Then there are currently 133,608 residents who have received the first stage of the COVID-19 vaccination, consisting of 1,392 health workers, 87,453 public service officers, and 5,848 elderly, and 15,351 youths aged 12-17 years, children aged 6 -11 years 18,262 people, and 5,302 mutual cooperation vaccine recipients. Until now there are still 43,068 health workers, public service workers, youth, children, and the elderly who have received the COVID-19 vaccine dose I but have not received the vaccine dose II because there are some of which have not reached their maturity and their health conditions are not yet possible.